Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bleifeld W., Mathey D., Hanrath P., Buss H., Effert S. Infarct size estimated from serial serum creatine phosphokinase in relation to left ventricular hemodynamics. Circulation. 1977 Feb;55(2):303–311. doi: 10.1161/01.cir.55.2.303. [DOI] [PubMed] [Google Scholar]
- Dewar H. A., Oliver M. F. Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials. Br Med J. 1971 Dec 25;4(5790):784–786. doi: 10.1136/bmj.4.5790.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Disopyramide in myocardial infarction. Lancet. 1977 Dec 3;2(8049):1185–1186. [PubMed] [Google Scholar]
- MCMICHAEL J., PARRY E. H. Prognosis and anticoagulant pro-phylaxis after coronary occlusion. Lancet. 1960 Nov 5;2(7158):991–998. doi: 10.1016/s0140-6736(60)92077-8. [DOI] [PubMed] [Google Scholar]
- Muller J. E., Maroko P. R., Braunwald E. Precordial electrocardiographic mapping. A technique to assess the efficacy of interventions designed to limit infarct size. Circulation. 1978 Jan;57(1):1–18. doi: 10.1161/01.cir.57.1.1. [DOI] [PubMed] [Google Scholar]
- SUZMAN M. M., RUSKIN H. D., GOLDBERG B. An evaluation of the effect of continuous long-term anticoagulant therapy on the prognosis of myocardial infarction: a report of 82 cases. Circulation. 1955 Sep;12(3):338–352. doi: 10.1161/01.cir.12.3.338. [DOI] [PubMed] [Google Scholar]
- Zainal N., Carmichael D. J., Griffiths J. W., Besterman E. M., Kidner P. H., Gillham A. D., Summers G. D. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. Lancet. 1977 Oct 29;2(8044):887–889. doi: 10.1016/s0140-6736(77)90829-7. [DOI] [PubMed] [Google Scholar]